Lilly could quietly bulk up on bone drugs-WEB ONLY
It may not have the flash and pizazz of psychiatric, cancer and heart drugs, but expect Eli Lilly and Co.’s osteoporosis franchise to steadily build itself to blockbuster status over the next decade. That’s the upshot of a June 1 report from Massachusetts-based Decision Resources Inc.. which predicts that Lilly’s drug Forteo and a new […]